(NASDAQ:IFRX), JENA, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference. Details are as follows: Guggenheim Securities 2nd Annual Healthcare Innovation ConferenceNovember 10 – 12, 2025 in Boston, MAFireside […]

InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference GlobeNewswire October 21, 2025 JENA, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference. Details are as

Second Phase Adds 353 Homes, Vast Retail Space to Emerging South Florida Locale Mill Creek Residential, a leading developer, owner-operator and investment manager specializing in premier rental housing across the U.S., today announced the start of preleasing at Modera Coral Springs Phase II, a contemporary mixed-use community in the heart of Coral Springs. https://mma.prnewswire.com/media/224987/mill_creek_logo.jpg The

Mutuum Finance (MUTM) to Enable ETH Lending and Borrowing in Upcoming V1 Protocol Launch GlobeNewswire October 21, 2025 Dubai, UAE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) has announced new details regarding its upcoming Version 1 (V1) protocol launch, confirming that ETH lending and borrowing will be among the first core features available

$11.35 Million USD; 5.9 MW Solar Project Built by PowerBank for Client The Project Generates Enough Electricity to Power Approx. 737 homes PowerBank Retains a 1 GW Development Pipeline PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103)(“PowerBank” or the “Company”), a leader in North American energy infrastructure development and asset ownership, is pleased to

Incline Equity Partners (“Incline”), a leading private equity firm dedicated to investing across the middle market, is pleased to announce the closing of a heavily oversubscribed single-asset continuation vehicle (“CV”) for Accredited Labs (the “Company”). The transaction closed with approximately $300 million in commitments, including significant participation by Incline's partners and employees. The meaningful GP

(Other OTC:LIMX),(OTC US:LIMX), LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) — Limitless X Holdings Inc. (OTCQX: LIMX), a global health, wellness, and lifestyle company founded by entrepreneur Jas Mathur, today announced plans to launch operations in India and select Asian markets in Q1 2026. For Mathur, who was born in New Delhi and raised in

Subtle Medical, Inc., a leader in AI-powered medical imaging solutions, today announced positive findings from a proof-of-concept (POC) study with Bayer, a leader in Radiology, evaluating Subtle Medical's investigational SubtleGAD™ technology. https://mma.prnewswire.com/media/2686843/Large_primary_subtle_medical_logo_2_Logo.jpg The study, including 39 patients undergoing imaging of the brain, conducted across five leading U.S. sites including Mayo Clinic, MD Anderson Cancer Center,

Study to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735 Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens to be Evaluated Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of an exploratory maintenance dosing study

Limitless X Announces Strategic India and Asia Launch in 2026, Uniting Health, Sports, Entertainment, and Global Cultural Powerhouses to Drive Scalable Growth and Market Expansion GlobeNewswire October 21, 2025 LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) — Limitless X Holdings Inc. (OTCQX: LIMX), a global health, wellness, and lifestyle company founded by entrepreneur Jas Mathur,